MedTrace Logo

Radiofrecuency and Supervised Exercise Versus Supervised Exercise in the Treatment of Patellofemoral Pain Syndrome.

NCT04538508 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2020-10-06

No results posted yet for this study

Summary

This study will analyze the effects of a non-invasive radiofrequency diathermy device added to knee exercises on the symptoms of patellofemoral pain syndrome. For this aim, a randomized clinical trial will be carried out with a control group that will perform supervised exercises and an experimental group that will add radiofrequency diathermy to supervised exercises. Diathermy treatment will be performed along three weeks, ten treatment sessions in total, while supervised exercises will be performed daily.

Outcomes to measure will include pain, knee function and quality of life

Conditions

  • Patellofemoral Pain Syndrome

Interventions

DEVICE

Diathermy

10 sessions of 12 minutes of radiofrequency diathermy at the anterior surface of the knee, in constant movement

OTHER

Supervised knee exercises

Daily hamstrings exercises, quadriceps exercises and hip exercises, 20 minutes of duration.

Sponsors & Collaborators

  • University of Seville

    collaborator OTHER

  • Andaluz Health Service

    collaborator OTHER_GOV

  • Universidad de Extremadura

    collaborator OTHER

  • University of Jaén

    lead OTHER

Principal Investigators

  • Manuel Albornoz-Cabello, PhD · University of Seville

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-07
Primary Completion
2020-10-02
Completion
2020-10-02

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04538508 on ClinicalTrials.gov